Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

D W Hanto

Showing results (71-80 of 93) with videos related to

Pageof 10
Sort By:
Transplantation Proceedings|February 1, 1989
Concomitant immunosuppression and donor-specific transfusions prior to renal transplantationC B Anderson, M D Jendrisak, M W Flye, et al.
Transplantation Proceedings|December 1, 1988
Renal allograft recipient immunomodulation by concomitant immunosuppression and donor-specific transfusionsC B Anderson, M D Jendrisak, M W Flye, et al.
Transplantation|November 1, 1991
Renal transplantation for systemic lupus erythematosus and recurrent lupus nephritis. A single-center experience and a review of the literatureJ A Goss, B R Cole, M D Jendrisak, et al.
American Journal of Transplantation : Official Journal of the American Society of Transplantation and the American Society of Transplant Surgeons|September 12, 2007
Evaluating living kidney donors: relationship types, psychosocial criteria, and consent processes at US transplant programsJ R Rodrigue, M Pavlakis, G M Danovitch, et al.
Transplantation|February 1, 1994
Induction immunosuppression with antilymphocyte globulin or OKT3 in cadaver kidney transplantation. Results of a single institution prospective randomized trialD W Hanto, M D Jendrisak, S K So, et al.
Therapeutic Drug Monitoring|August 1, 1994
Variations in serum OKT3 concentration based upon age, sex, transplanted organ, treatment regimen, and anti-OKT3 antibody statusT J Schroeder, A T Michael, M R First, et al.
American Journal of Transplantation : Official Journal of the American Society of Transplantation and the American Society of Transplant Surgeons|September 12, 2007
The medical evaluation of living kidney donors: a survey of US transplant centersD A Mandelbrot, M Pavlakis, G M Danovitch, et al.
Annals of Surgery|September 1, 1983
Epstein-Barr virus (EBV) induced polyclonal and monoclonal B-cell lymphoproliferative diseases occurring after renal transplantation. Clinical, pathologic, and virologic findings and implications for therapyD W Hanto, K J Gajl-Peczalska, G Frizzera, et al.
Cancer Research|November 1, 1981
Polymorphic diffuse B-cell hyperplasias and lymphomas in renal transplant recipientsG Frizzera, D W Hanto, K J Gajl-Peczalska, et al.
The New England Journal of Medicine|April 15, 1982
Epstein-Barr virus-induced B-cell lymphoma after renal transplantation: acyclovir therapy and transition from polyclonal to monoclonal B-cell proliferationD W Hanto, G Frizzera, K J Gajl-Peczalska, et al.
Pageof 10

Showing results (71-80 of 93) with videos related to

Sort By:
Pageof 10
Transplantation Proceedings|February 1, 1989
Concomitant immunosuppression and donor-specific transfusions prior to renal transplantationC B Anderson, M D Jendrisak, M W Flye, et al.
Transplantation Proceedings|December 1, 1988
Renal allograft recipient immunomodulation by concomitant immunosuppression and donor-specific transfusionsC B Anderson, M D Jendrisak, M W Flye, et al.
Transplantation|November 1, 1991
Renal transplantation for systemic lupus erythematosus and recurrent lupus nephritis. A single-center experience and a review of the literatureJ A Goss, B R Cole, M D Jendrisak, et al.
American Journal of Transplantation : Official Journal of the American Society of Transplantation and the American Society of Transplant Surgeons|September 12, 2007
Evaluating living kidney donors: relationship types, psychosocial criteria, and consent processes at US transplant programsJ R Rodrigue, M Pavlakis, G M Danovitch, et al.
Transplantation|February 1, 1994
Induction immunosuppression with antilymphocyte globulin or OKT3 in cadaver kidney transplantation. Results of a single institution prospective randomized trialD W Hanto, M D Jendrisak, S K So, et al.
Therapeutic Drug Monitoring|August 1, 1994
Variations in serum OKT3 concentration based upon age, sex, transplanted organ, treatment regimen, and anti-OKT3 antibody statusT J Schroeder, A T Michael, M R First, et al.
American Journal of Transplantation : Official Journal of the American Society of Transplantation and the American Society of Transplant Surgeons|September 12, 2007
The medical evaluation of living kidney donors: a survey of US transplant centersD A Mandelbrot, M Pavlakis, G M Danovitch, et al.
Annals of Surgery|September 1, 1983
Epstein-Barr virus (EBV) induced polyclonal and monoclonal B-cell lymphoproliferative diseases occurring after renal transplantation. Clinical, pathologic, and virologic findings and implications for therapyD W Hanto, K J Gajl-Peczalska, G Frizzera, et al.
Cancer Research|November 1, 1981
Polymorphic diffuse B-cell hyperplasias and lymphomas in renal transplant recipientsG Frizzera, D W Hanto, K J Gajl-Peczalska, et al.
The New England Journal of Medicine|April 15, 1982
Epstein-Barr virus-induced B-cell lymphoma after renal transplantation: acyclovir therapy and transition from polyclonal to monoclonal B-cell proliferationD W Hanto, G Frizzera, K J Gajl-Peczalska, et al.
Pageof 10